Innate Pharma to start phase I clinical trial of monalizumab
Monday, February 08, 2016
Innate Pharma SA announces the start of phase I clinical trial of monalizumab in combination with durvalumab.
This fifth trial with monalizumab completes roll-out of initial clinical plan, due to start reading out in 2017.
Trial will include up to 208 patients, and will be performed in United States and in Europe.
reuters.com
